Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics manufacturing by expanding capabilities and expertise.
Peter DeYoung, CEO, Piramal Pharma Limited
Advertisement
Articles by Peter DeYoung, CEO, Piramal Pharma Limited
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
3
PharmTech Weekly News Roundup — Week of November 10, 2025
4
